News Conference News PCR London Valves 2016 Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon Shelley Wood September 20, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Daily News High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE Yael L. Maxwell July 22, 2016
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
Presentation TVT 2016 An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability Presenter: Raj Makkar June 17, 2016
Presentation TVT 2016 The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR Presenter: Azeem Latib June 17, 2016
News Features Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent Caitlin E. Cox June 17, 2016
Presentation CCVVC 2016 Subclinical Leaflet Thrombosis Post-TAVR Presenter: Gian Paolo Ussia June 16, 2016
Presentation TVT 2016 TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation Presenter: Leo Marcoff, MD June 16, 2016
Presentation TVT 2016 The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves Presenter: Lars Sondergaard June 16, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2016 Shelley Wood May 31, 2016
News Daily News Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests Todd Neale May 12, 2016
News Daily News When Problems Arise With Prosthetic Heart Valves, Multimodality Imaging Is Needed, Say European Guidelines Todd Neale May 06, 2016
News Daily News Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena Michael O'Riordan April 29, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2016 Shelley Wood March 30, 2016
News Opinion Editor's Corner ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More Shelley Wood March 28, 2016